Further study on the deacetylation function of SIRT3 in mitochondria and its upstream and downstream molecular targets is of great significance for elucidating the pathogenesis of NAFLD and preparing appropriate drugs to prevent and treat NAFLD. The gene discussed is SIRT3; the disease is metabolic dysfunction-associated steatotic liver disease.